RAFAEL HOLDINGS INC-CLASS B (RFL)

Company Profile

Rafael Holdings, Inc. owns interest in commercial real estate assets and clinical stage pharmaceutical companies. The company is headquartered in Newark, New Jersey and currently employs 13 full-time employees. The company went IPO on 2018-03-12. The firm's segments include healthcare and real estate. The firm's investments include Cornerstone Pharmaceuticals, Inc., which is a cancer metabolism-based therapeutics company; LipoMedix Pharmaceuticals Ltd., which is a clinical-stage pharmaceutical company; Barer Institute Inc., which is a preclinical cancer metabolism research operation; Cyclo Therapeutics Inc., which is a clinical-stage biotechnology company dedicated to developing medicines for patients and families living with diseases through its therapeutic asset like Trappsol and Cyclo; Day Three Labs, Inc., which offers pharmaceutical-grade technology like Unlokt, and Rafael Medical Devices, LLC, which is an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries. Its real estate segment comprises of a portion of a commercial building in Israel.

Company Info

RAFAEL HOLDINGS INC-CLASS B

520 Broad St

Newark NEW JERSEY 07102

P: 12126581450

CEO: Ameet Mallik

Employees: 13

Website: https://rafaelholdings.com